Zobrazeno 1 - 10
of 72
pro vyhledávání: '"D Gaziev"'
Autor:
D Gaziev, Guido Lucarelli
Publikováno v:
Expert Opinion on Investigational Drugs. 10:909-923
Chronic graft-versus-host disease (cGvHD) continues to be the major problem in long-term survivors of allogeneic haematopoietic stem cell transplants and is the principal cause of morbidity and non-relapse mortality. Over the past twenty years, diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505eb4c14bc4f52592cf1e1a3e7261fc
https://doi.org/10.1517/13543784.10.5.909
https://doi.org/10.1517/13543784.10.5.909
Autor:
Claudio Giardini, Emanuele Angelucci, D Gaziev, Guido Lucarelli, Donatella Baronciani, G Izzi, M Galimberti, B Erer, Paola Polchi
Publikováno v:
Scopus-Elsevier
Patients undergoing bone marrow transplantation are profoundly immunosuppressed as a result of their intensive myeloablative chemotherapy and are at high risk for opportunistic fungal infections mainly caused by Candida spp and Aspergillus spp. Trich
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aebd059b6d11f9820f90e838b6dab00
https://doi.org/10.1038/sj.bmt.1702231
https://doi.org/10.1038/sj.bmt.1702231
Autor:
Claudio Giardini, Emanuele Angelucci, Paola Polchi, Guido Lucarelli, Donatella Baronciani, Buket Erer, Maria Galimberti, D Gaziev
Publikováno v:
Transplantation. 63:854-860
We analyzed risk factors in 724 patients evaluable for acute graft-versus-host disease (GVHD) and in 614 patients evaluable for chronic GVHD who had received bone marrow transplantation (BMT) from HLA-identical siblings and/or parents for thalassemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48501f79eae74d576987d453c99d545f
https://doi.org/10.1097/00007890-199703270-00011
https://doi.org/10.1097/00007890-199703270-00011
Publikováno v:
Bone Marrow Transplantation. 19:629-631
A case of Kaposi's sarcoma (KS) in an allogenic BMT recipient is reported. A 26-year-old man underwent allogeneic bone marrow transplantation for microdrepanocytosis. He received prolonged immunosuppressive therapy for mild chronic GVHD. Two years af
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4cb1209596273d5167351b807eb435
https://doi.org/10.1038/sj.bmt.1700703
https://doi.org/10.1038/sj.bmt.1700703
Autor:
B Erer, Pietro Sodani, Paola Polchi, Marco Andreani, Guido Lucarelli, Barbarella Lucarelli, Donatella Baronciani, Claudio Giardini, Reginald A. Clift, D Gaziev, Emanuele Angelucci, M Manna, Nesci S
Publikováno v:
Blood. 104(4)
When prepared for transplantation with busulfan (BU) 14 mg/kg and cyclophosphamide (CY) 120 to 160 mg/kg, patients with thalassemia in risk class 3, aged younger than 17 years, who receive transplants from HLA-identical donors, had a 30% incidence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b3deb7344343cbf15604758e7f1523f
https://pubmed.ncbi.nlm.nih.gov/15039283
https://pubmed.ncbi.nlm.nih.gov/15039283
Autor:
M Galimberti, B Erer, D Gaziev, Claudio Giardini, Paola Polchi, Emanuele Angelucci, Guido Lucarelli, Pietro Sodani, Donatella Baronciani
Publikováno v:
Bone marrow transplantation. 27(1)
We analyzed the results of a three or more drug combination as treatment for moderate or severe cGVHD developing after transplantation for thalassemia, in 45 patients with median age of 11 (range 2-26) years. Eighteen patients received a three drug r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac42c2a3b6c440036642a3a1d24d824
https://pubmed.ncbi.nlm.nih.gov/11244437
https://pubmed.ncbi.nlm.nih.gov/11244437
Publikováno v:
Bone marrow transplantation. 25(7)
Despite conventional and new therapies for the treatment of chronic GVHD (cGVHD), this syndrome continues to account for significant morbidity and mortality after allogeneic hematopoietic stem cell transplantation. With the expanded use of allogeneic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20bcda8a8e5a260faec86b9406733348
https://pubmed.ncbi.nlm.nih.gov/10982297
https://pubmed.ncbi.nlm.nih.gov/10982297
Autor:
G, Lucarelli, R A, Clift, M, Galimberti, E, Angelucci, C, Giardini, D, Baronciani, P, Polchi, M, Andreani, D, Gaziev, B, Erer, A, Ciaroni, F, D'Adamo, F, Albertini, P, Muretto
Publikováno v:
Blood. 93(4)
One hundred seven adult patients with thalassemia aged from 17 through 35 years and transplanted from HLA-identical siblings between November 1988 and September 1996 were evaluated on December 31, 1997. The outcome experience of 20 consecutive patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::527a98c8d849c30dd7b94b478906b6b6
https://pubmed.ncbi.nlm.nih.gov/9949158
https://pubmed.ncbi.nlm.nih.gov/9949158
Autor:
E, Angelucci, P, Muretto, G, Lucarelli, M, Ripalti, D, Baronciani, B, Erer, M, Galimberti, C, Giardini, D, Gaziev, P, Polchi
Publikováno v:
Blood. 90(3)
In thalassemia after successful bone marrow transplantation (BMT), iron overload remains an important cause of morbidity. After BMT, patients have normal erythropoiesis capable of producing a hyperplastic response to phlebotomy so that this procedure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d8f03f8e68c95e51425e7432a722448
https://pubmed.ncbi.nlm.nih.gov/9242528
https://pubmed.ncbi.nlm.nih.gov/9242528
Autor:
D, Gaziev, P, Polchi, M, Galimberti, E, Angelucci, C, Giardini, D, Baronciani, B, Erer, G, Lucarelli
Publikováno v:
Transplantation. 63(6)
We analyzed risk factors in 724 patients evaluable for acute graft-versus-host disease (GVHD) and in 614 patients evaluable for chronic GVHD who had received bone marrow transplantation (BMT) from HLA-identical siblings and/or parents for thalassemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::98c861495fc838261cfa557eb117a4de
https://pubmed.ncbi.nlm.nih.gov/9089226
https://pubmed.ncbi.nlm.nih.gov/9089226